.png)
Medical Marijuana Market by Application - Global Industry Analysis & Forecast to 2027
Published On : November 2019 Pages : 150 Category: Pharma & Healthcare Report Code : HC116879
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Medical Marijuana Market By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Medical Marijuana Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Medicinal cannabis, likewise alluded to as Medical Marijuana, is the natural, entire or concentrate of Maryjane plant utilized for treating ailment or side effects of different conditions. In spite of the fact that, the U.S. FDA is yet to affirm cannabis plant as medication, logical research and investigation of the plant's synthetic substances have prompted FDA endorsement of two drugs. These meds comprise of THC (Tetrahydrocannabinol) and are utilized to treat chemotherapy-actuated queasiness.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Medical Marijuana Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
Legalization of medical use of marijuana in Germany in 2022 created a domino effect on other European countries for initiation marijuana-related research programs.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- ABcann Medicinals, Inc.
- Aurora Cannabis, Inc.
- Canopy Growth Corporation
- Green Relief Inc.
- Aphria, Inc.
- Cannabis Sativa Inc.
- GW Pharmaceuticals
- Emerald Health Therapeutics Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Medical Marijuana Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Pain Management
o Muscle Spasms
o Nausea
o Anorexia
o Seizures
· Medical Marijuana Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o ABcann Medicinals, Inc.
o Aurora Cannabis, Inc.
o Canopy Growth Corporation
o Green Relief Inc.
o Aphria, Inc.
o Cannabis Sativa Inc.
o GW Pharmaceuticals
o Emerald Health Therapeutics Inc.
· Medical Marijuana Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Medical Marijuana Market, By Country
o U.S. Medical Marijuana Market
o Canada Medical Marijuana Market
o Mexico Medical Marijuana Market
o Europe
§ Europe Medical Marijuana Market, By Country
o Germany Medical Marijuana Market
o UK Medical Marijuana Market
o France Medical Marijuana Market
o Russia Medical Marijuana Market
o Italy Medical Marijuana Market
o Rest of Europe Medical Marijuana Market
o Asia-Pacific
§ Asia-Pacific Medical Marijuana Market, By Country
o China Medical Marijuana Market
o Japan Medical Marijuana Market
o South Korea Medical Marijuana Market
o India Medical Marijuana Market
o Southeast Asia Medical Marijuana Market
o Rest of Asia-Pacific Medical Marijuana Market
o South America
§ South America Medical Marijuana Market
o Brazil Medical Marijuana Market
o Argentina Medical Marijuana Market
o Columbia Medical Marijuana Market
o Rest of South America Medical Marijuana Market
o Middle East and Africa
§ Middle East and Africa Medical Marijuana Market
o Saudi Arabia Medical Marijuana Market
o UAE Medical Marijuana Market
o Egypt Medical Marijuana Market
o Nigeria Medical Marijuana Market
o South Africa Medical Marijuana Market
o Rest of MEA Medical Marijuana Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Medical Marijuana Market, By Application
5.1. Introduction
5.2. Global Medical Marijuana Revenue and Market Share by Application (2017-2027)
5.2.1. Global Medical Marijuana Revenue and Revenue Share by Application (2017-2027)
5.3. Pain Management
5.3.1. Global Pain Management Revenue and Growth Rate (2017-2027)
5.4. Muscle Spasms
5.4.1. Global Muscle Spasms Revenue and Growth Rate (2017-2027)
5.5. Nausea
5.5.1. Global Nausea Revenue and Growth Rate (2017-2027)
5.6. Anorexia
5.6.1. Global Anorexia Revenue and Growth Rate (2017-2027)
5.7. Seizures
5.7.1. Global Seizures Revenue and Growth Rate (2017-2027)
6. Medical Marijuana Market, By Region
6.1. Introduction
6.2. Global Medical Marijuana Revenue and Market Share by Regions
6.2.1. Global Medical Marijuana Revenue by Regions (2017-2027)
6.3. North America Medical Marijuana by Countries
6.3.1. North America Medical Marijuana Revenue and Growth Rate (2017-2027)
6.3.2. North America Medical Marijuana Revenue (Million USD) by Countries (2017-2027)
6.3.3. United States
6.3.3.1. United States Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.4. Canada
6.3.4.1. Canada Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.5. Mexico
6.3.5.1. Mexico Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.4. Europe Medical Marijuana by Countries
6.4.1. Europe Medical Marijuana Revenue and Growth Rate (2017-2027)
6.4.2. Europe Medical Marijuana Revenue (Million USD) by Countries (2017-2027)
6.4.3. Germany
6.4.3.1. Germany Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.4. France
6.4.4.1. France Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.5. UK
6.4.5.1. UK Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.6. Russia
6.4.6.1. Russia Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.7. Italy
6.4.7.1. Italy Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.5. Asia-Pacific Medical Marijuana by Countries
6.5.1. Asia-Pacific Medical Marijuana Revenue and Growth Rate (2017-2027)
6.5.2. Asia-Pacific Medical Marijuana Revenue (Million USD) by Countries (2017-2027)
6.5.3. China
6.5.3.1. China Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.4. Japan
6.5.4.1. Japan Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.5. Korea
6.5.5.1. Korea Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6. India
6.5.6.1. India Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.7. Southeast Asia
6.5.7.1. Southeast Asia Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.8. Rest of Asia-Pacific
6.5.8.1. Rest of Asia-Pacific Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.6. South America Medical Marijuana by Countries
6.6.1. South America Medical Marijuana Revenue and Growth Rate (2017-2027)
6.6.2. South America Medical Marijuana Revenue (Million USD) by Countries (2017-2027)
6.6.3. Brazil
6.6.3.1. Brazil Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.4. Argentina
6.6.4.1. Argentina Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.5. Columbia
6.6.5.1. Columbia Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.6. Rest of South America
6.6.6.1. Rest of South America Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.7. Middle East and Africa Medical Marijuana by Countries
6.7.1. Middle East and Africa Medical Marijuana Revenue and Growth Rate (2017-2027)
6.7.2. Middle East and Africa Medical Marijuana Revenue (Million USD) by Countries (2017-2027)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.4. United Arab Emirates
6.7.4.1. United Arab Emirates Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.5. Egypt
6.7.5.1. Egypt Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.6. Nigeria
6.7.6.1. Nigeria Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.7. South Africa
6.7.7.1. South Africa Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.8. Turkey
6.7.8.1. Turkey Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.9. Rest of Middle East and Africa
6.7.9.1. Rest of Middle East and Africa Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
7. Company Profiles
7.1. ABcann Medicinals, Inc.
7.1.1. Business Overview
7.1.2. Service Portfolio
7.1.3. Strategic Developments
7.1.4. Financial Overview
7.2. Aurora Cannabis, Inc.
7.2.1. Business Overview
7.2.2. Service Portfolio
7.2.3. Strategic Developments
7.2.4. Financial Overview
7.3. Canopy Growth Corporation
7.3.1. Business Overview
7.3.2. Service Portfolio
7.3.3. Strategic Developments
7.3.4. Financial Overview
7.4. Green Relief Inc.
7.4.1. Business Overview
7.4.2. Service Portfolio
7.4.3. Strategic Developments
7.4.4. Financial Overview
7.5. Aphria, Inc.
7.5.1. Business Overview
7.5.2. Service Portfolio
7.5.3. Strategic Developments
7.5.4. Financial Overview
7.6. Cannabis Sativa Inc.
7.6.1. Business Overview
7.6.2. Service Portfolio
7.6.3. Strategic Developments
7.6.4. Financial Overview
7.7. GW Pharmaceuticals
7.7.1. Business Overview
7.7.2. Service Portfolio
7.7.3. Strategic Developments
7.7.4. Financial Overview
7.8. Emerald Health Therapeutics Inc.
7.8.1. Business Overview
7.8.2. Service Portfolio
7.8.3. Strategic Developments
7.8.4. Financial Overview
8. Medical Marijuana Market Forecast (2017-2027)
8.1. Global Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2027)
8.2. Medical Marijuana Market Forecast by Regions (2017-2027)
8.2.1. North America Medical Marijuana Market Forecast (2017-2027)
8.2.1.1. United States Medical Marijuana Market Forecast (2017-2027)
8.2.1.2. Canada Medical Marijuana Market Forecast (2017-2027)
8.2.1.3. Mexico Medical Marijuana Market Forecast (2017-2027)
8.2.2. Europe Medical Marijuana Market Forecast (2017-2027)
8.2.2.1. Germany Medical Marijuana Market Forecast (2017-2027)
8.2.2.2. France Medical Marijuana Market Forecast (2017-2027)
8.2.2.3. UK Medical Marijuana Market Forecast (2017-2027)
8.2.2.4. Russia Medical Marijuana Market Forecast (2017-2027)
8.2.2.5. Italy Medical Marijuana Market Forecast (2017-2027)
8.2.2.6. Rest of Europe Medical Marijuana Market Forecast (2017-2027)
8.2.3. Asia-Pacific Medical Marijuana Market Forecast (2017-2027)
8.2.3.1. China Medical Marijuana Market Forecast (2017-2027)
8.2.3.2. Japan Medical Marijuana Market Forecast (2017-2027)
8.2.3.3. Korea Medical Marijuana Market Forecast (2017-2027)
8.2.3.4. India Medical Marijuana Market Forecast (2017-2027)
8.2.3.5. Southeast Asia Medical Marijuana Market Forecast (2017-2027)
8.2.3.6. Rest of Asia-Pacific Medical Marijuana Market Forecast (2017-2027)
8.2.4. South America Medical Marijuana Market Forecast (2017-2027)
8.2.4.1. Brazil Medical Marijuana Market Forecast (2017-2027)
8.2.4.2. Argentina Medical Marijuana Market Forecast (2017-2027)
8.2.4.3. Columbia Medical Marijuana Market Forecast (2017-2027)
8.2.4.4. Rest of South America Medical Marijuana Market Forecast (2017-2027)
8.2.5. Middle East and Africa Medical Marijuana Market Forecast (2017-2027)
8.2.5.1. Saudi Arabia Medical Marijuana Market Forecast (2017-2027)
8.2.5.2. United Arab Emirates Medical Marijuana Market Forecast (2017-2027)
8.2.5.3. Egypt Medical Marijuana Market Forecast (2017-2027)
8.2.5.4. Nigeria Medical Marijuana Market Forecast (2017-2027)
8.2.5.5. South Africa Medical Marijuana Market Forecast (2017-2027)
8.2.5.6. Turkey Medical Marijuana Market Forecast (2017-2027)
8.2.5.7. Rest of Middle East and Africa Medical Marijuana Market Forecast (2017-2027)
8.3. Medical Marijuana Market Forecast by Application (2017-2027)
8.3.1. Medical Marijuana Forecast by Application (2017-2027)
8.3.2. Medical Marijuana Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Medical Marijuana Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Medical Marijuana Revenue and Revenue Share by Application (2017-2018)
Figure Global Pain Management Revenue and Growth Rate (2017-2018)
Figure Global Muscle Spasms Revenue and Growth Rate (2017-2018)
Figure Global Nausea Revenue and Growth Rate (2017-2018)
Figure Global Anorexia Revenue and Growth Rate (2017-2018)
Figure Global Seizures Revenue and Growth Rate (2017-2018)
Table Global Medical Marijuana Revenue by Regions (2017-2018)
Figure North America Medical Marijuana Growth Rate (2017-2018)
Figure North America Medical Marijuana Revenue and Growth Rate (2017-2018)
Figure North America Medical Marijuana by Countries (2017-2018)
Figure North America Medical Marijuana Revenue (Million USD) by Countries (2017-2018)
Figure United States Medical Marijuana Growth Rate (2017-2018)
Figure United States Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Medical Marijuana Growth Rate (2017-2018)
Figure Canada Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Medical Marijuana Growth Rate (2017-2018)
Figure Mexico Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Medical Marijuana Growth Rate (2017-2018)
Figure Europe Medical Marijuana Revenue and Growth Rate (2017-2018)
Figure Europe Medical Marijuana by Countries (2017-2018)
Figure Europe Medical Marijuana Revenue (Million USD) by Countries (2017-2018)
Figure Germany Medical Marijuana Growth Rate (2017-2018)
Figure Germany Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Medical Marijuana Growth Rate (2017-2018)
Figure France Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Medical Marijuana Growth Rate (2017-2018)
Figure UK Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Medical Marijuana Growth Rate (2017-2018)
Figure Russia Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Medical Marijuana Growth Rate (2017-2018)
Figure Italy Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Medical Marijuana Growth Rate (2017-2018)
Figure Rest of Europe Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Medical Marijuana Growth Rate (2017-2018)
Figure Asia-Pacific Medical Marijuana Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Medical Marijuana by Countries (2017-2018)
Figure Asia-Pacific Medical Marijuana Revenue (Million USD) by Countries (2017-2018)
Figure China Medical Marijuana Growth Rate (2017-2018)
Figure China Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Medical Marijuana Growth Rate (2017-2018)
Figure Japan Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Medical Marijuana Growth Rate (2017-2018)
Figure Korea Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Medical Marijuana Growth Rate (2017-2018)
Figure India Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Medical Marijuana Growth Rate (2017-2018)
Figure Southeast Asia Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Medical Marijuana Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Medical Marijuana Growth Rate (2017-2018)
Figure South America Medical Marijuana Revenue and Growth Rate (2017-2018)
Figure South America Medical Marijuana by Countries (2017-2018)
Figure South America Medical Marijuana Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Medical Marijuana Growth Rate (2017-2018)
Figure Brazil Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Medical Marijuana Growth Rate (2017-2018)
Figure Argentina Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Medical Marijuana Growth Rate (2017-2018)
Figure Columbia Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Medical Marijuana Growth Rate (2017-2018)
Figure Rest of South America Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Medical Marijuana Growth Rate (2017-2018)
Figure Middle East and Africa Medical Marijuana Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Medical Marijuana by Countries (2017-2018)
Figure Middle East and Africa Medical Marijuana Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Medical Marijuana Growth Rate (2017-2018)
Figure Saudi Arabia Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Medical Marijuana Growth Rate (2017-2018)
Figure United Arab Emirates Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Medical Marijuana Growth Rate (2017-2018)
Figure Egypt Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Medical Marijuana Growth Rate (2017-2018)
Figure Nigeria Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Medical Marijuana Growth Rate (2017-2018)
Figure South Africa Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Medical Marijuana Growth Rate (2017-2018)
Figure Turkey Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Medical Marijuana Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Medical Marijuana Revenue (Millions USD) and Growth Rate (2017-2018)
Table ABcann Medicinals, Inc. Medical Marijuana Financial Overview
Table Aurora Cannabis, Inc. Medical Marijuana Financial Overview
Table Canopy Growth Corporation Medical Marijuana Financial Overview
Table Green Relief Inc. Medical Marijuana Financial Overview
Table Aphria, Inc. Medical Marijuana Financial Overview
Table Cannabis Sativa Inc. Medical Marijuana Financial Overview
Table GW Pharmaceuticals Medical Marijuana Financial Overview
Table Emerald Health Therapeutics Inc. Medical Marijuana Financial Overview
Figure Global Medical Marijuana Revenue (Millions USD) and Growth Rate (2018-2025)
Table Medical Marijuana Market Forecast by Regions (2018-2025)
Figure North America Medical Marijuana Market Forecast (2018-2025)
Figure United States Medical Marijuana Market Forecast (2018-2025)
Figure Canada Medical Marijuana Market Forecast (2018-2025)
Figure Mexico Medical Marijuana Market Forecast (2018-2025)
Figure Europe Medical Marijuana Market Forecast (2018-2025)
Figure Germany Medical Marijuana Market Forecast (2018-2025)
Figure France Medical Marijuana Market Forecast (2018-2025)
Figure UK Medical Marijuana Market Forecast (2018-2025)
Figure Russia Medical Marijuana Market Forecast (2018-2025)
Figure Italy Medical Marijuana Market Forecast (2018-2025)
Figure Rest of Europe Medical Marijuana Market Forecast (2018-2025)
Figure Asia-Pacific Medical Marijuana Market Forecast (2018-2025)
Figure China Medical Marijuana Market Forecast (2018-2025)
Figure Japan Medical Marijuana Market Forecast (2018-2025)
Figure Korea Medical Marijuana Market Forecast (2018-2025)
Figure India Medical Marijuana Market Forecast (2018-2025)
Figure Southeast Asia Medical Marijuana Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Medical Marijuana Market Forecast (2018-2025)
Figure South America Medical Marijuana Market Forecast (2018-2025)
Figure Brazil Medical Marijuana Market Forecast (2018-2025)
Figure Argentina Medical Marijuana Market Forecast (2018-2025)
Figure Columbia Medical Marijuana Market Forecast (2018-2025)
Figure Rest of South America Medical Marijuana Market Forecast (2018-2025)
Figure Middle East and Africa Medical Marijuana Market Forecast (2018-2025)
Figure Saudi Arabia Medical Marijuana Market Forecast (2018-2025)
Figure United Arab Emirates Medical Marijuana Market Forecast (2018-2025)
Figure Egypt Medical Marijuana Market Forecast (2018-2025)
Figure Nigeria Medical Marijuana Market Forecast (2018-2025)
Figure South Africa Medical Marijuana Market Forecast (2018-2025)
Figure Turkey Medical Marijuana Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Medical Marijuana Market Forecast (2018-2025)
Figure Global Medical Marijuana Forecast by Application (2018-2025)
Figure Global Medical Marijuana Market Share Forecast by Application (2018-2025)
Figure Global Medical Marijuana Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|